ASX - By Stock
|
CYP |
Re:
2020 - A Year Full Of Potentials
|
|
TTE
|
507 |
1.5M |
0 |
20/02/20 |
20/02/20 |
ASX - By Stock
|
507
|
1.5M
|
0
|
|
ASX - By Stock
|
CYP |
Re:
2020 - A Year Full Of Potentials
|
|
TTE
|
507 |
1.5M |
1 |
20/02/20 |
20/02/20 |
ASX - By Stock
|
507
|
1.5M
|
1
|
|
ASX - By Stock
|
CYP |
Re:
2020 - A Year Full Of Potentials
|
|
TTE
|
507 |
1.5M |
1 |
20/02/20 |
20/02/20 |
ASX - By Stock
|
507
|
1.5M
|
1
|
|
ASX - By Stock
|
CYP |
Re:
2020 - A Year Full Of Potentials
|
|
TTE
|
507 |
1.5M |
1 |
20/02/20 |
20/02/20 |
ASX - By Stock
|
507
|
1.5M
|
1
|
|
ASX - By Stock
|
CYP |
Re:
2020 - A Year Full Of Potentials
|
|
TTE
|
507 |
1.5M |
0 |
20/02/20 |
20/02/20 |
ASX - By Stock
|
507
|
1.5M
|
0
|
|
ASX - By Stock
|
CYP |
Re:
2020 - A Year Full Of Potentials
|
|
TTE
|
507 |
1.5M |
0 |
20/02/20 |
20/02/20 |
ASX - By Stock
|
507
|
1.5M
|
0
|
|
ASX - By Stock
|
CYP |
Re:
2020 - A Year Full Of Potentials
|
|
TTE
|
507 |
1.5M |
1 |
20/02/20 |
20/02/20 |
ASX - By Stock
|
507
|
1.5M
|
1
|
|
ASX - By Stock
|
CYP |
Re:
2020 - A Year Full Of Potentials
|
|
TTE
|
507 |
1.5M |
1 |
20/02/20 |
20/02/20 |
ASX - By Stock
|
507
|
1.5M
|
1
|
|
ASX - By Stock
|
CYP |
Re:
2020 - A Year Full Of Potentials
|
|
TTE
|
507 |
1.5M |
1 |
20/02/20 |
20/02/20 |
ASX - By Stock
|
507
|
1.5M
|
1
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
TTE
|
23K |
13M |
1 |
20/02/20 |
20/02/20 |
ASX - By Stock
|
23K
|
13M
|
1
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
TTE
|
23K |
13M |
5 |
20/02/20 |
20/02/20 |
ASX - By Stock
|
23K
|
13M
|
5
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
TTE
|
23K |
13M |
2 |
20/02/20 |
20/02/20 |
ASX - By Stock
|
23K
|
13M
|
2
|
|
ASX - By Stock
|
CYP |
Re:
2020 - A Year Full Of Potentials
|
|
TTE
|
507 |
1.5M |
0 |
20/02/20 |
20/02/20 |
ASX - By Stock
|
507
|
1.5M
|
0
|
|
ASX - By Stock
|
CYP |
Re:
2020 - A Year Full Of Potentials
|
|
TTE
|
507 |
1.5M |
0 |
20/02/20 |
20/02/20 |
ASX - By Stock
|
507
|
1.5M
|
0
|
|
ASX - By Stock
|
CYP |
Re:
2020 - A Year Full Of Potentials
|
|
TTE
|
507 |
1.5M |
1 |
20/02/20 |
20/02/20 |
ASX - By Stock
|
507
|
1.5M
|
1
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
TTE
|
23K |
13M |
15 |
19/02/20 |
19/02/20 |
ASX - By Stock
|
23K
|
13M
|
15
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
TTE
|
23K |
13M |
4 |
19/02/20 |
19/02/20 |
ASX - By Stock
|
23K
|
13M
|
4
|
|
ASX - By Stock
|
BRN |
Re:
Where to from here?
|
|
TTE
|
1.7K |
995K |
8 |
19/02/20 |
19/02/20 |
ASX - By Stock
|
1.7K
|
995K
|
8
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
TTE
|
23K |
13M |
0 |
19/02/20 |
19/02/20 |
ASX - By Stock
|
23K
|
13M
|
0
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
TTE
|
23K |
13M |
6 |
19/02/20 |
19/02/20 |
ASX - By Stock
|
23K
|
13M
|
6
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
TTE
|
23K |
13M |
2 |
19/02/20 |
19/02/20 |
ASX - By Stock
|
23K
|
13M
|
2
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
TTE
|
23K |
13M |
1 |
19/02/20 |
19/02/20 |
ASX - By Stock
|
23K
|
13M
|
1
|
|
ASX - By Stock
|
BRN |
Re:
Where to from here?
|
|
TTE
|
1.7K |
995K |
7 |
19/02/20 |
19/02/20 |
ASX - By Stock
|
1.7K
|
995K
|
7
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
TTE
|
23K |
13M |
1 |
19/02/20 |
19/02/20 |
ASX - By Stock
|
23K
|
13M
|
1
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
TTE
|
23K |
13M |
9 |
19/02/20 |
19/02/20 |
ASX - By Stock
|
23K
|
13M
|
9
|
|
ASX - By Stock
|
BRN |
Re:
Where to from here?
|
|
TTE
|
1.7K |
995K |
6 |
19/02/20 |
19/02/20 |
ASX - By Stock
|
1.7K
|
995K
|
6
|
|
ASX - By Stock
|
IXC |
Re:
Why IXC is a Strong BUY awaiting Phase 2 results in March 2020
|
|
TTE
|
46 |
18K |
1 |
19/02/20 |
19/02/20 |
ASX - By Stock
|
46
|
18K
|
1
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
TTE
|
23K |
13M |
5 |
19/02/20 |
19/02/20 |
ASX - By Stock
|
23K
|
13M
|
5
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
TTE
|
23K |
13M |
4 |
18/02/20 |
18/02/20 |
ASX - By Stock
|
23K
|
13M
|
4
|
|
ASX - By Stock
|
MSB |
Re:
The MSB pattern
|
|
TTE
|
184 |
1.1M |
8 |
18/02/20 |
18/02/20 |
ASX - By Stock
|
184
|
1.1M
|
8
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
TTE
|
23K |
13M |
9 |
18/02/20 |
18/02/20 |
ASX - By Stock
|
23K
|
13M
|
9
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
TTE
|
23K |
13M |
2 |
18/02/20 |
18/02/20 |
ASX - By Stock
|
23K
|
13M
|
2
|
|
ASX - By Stock
|
MSB |
Re:
MSB
|
|
TTE
|
9 |
12K |
2 |
18/02/20 |
18/02/20 |
ASX - By Stock
|
9
|
12K
|
2
|
|
ASX - By Stock
|
CYP |
Re:
Mcnamm
|
|
TTE
|
28 |
22K |
3 |
18/02/20 |
18/02/20 |
ASX - By Stock
|
28
|
22K
|
3
|
|
ASX - By Stock
|
BRN |
Re:
Brainchip inc and TATA
|
|
TTE
|
45 |
34K |
1 |
18/02/20 |
18/02/20 |
ASX - By Stock
|
45
|
34K
|
1
|
|
ASX - By Stock
|
BRN |
Re:
my premise
|
|
TTE
|
32 |
20K |
2 |
17/02/20 |
17/02/20 |
ASX - By Stock
|
32
|
20K
|
2
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
TTE
|
23K |
13M |
3 |
17/02/20 |
17/02/20 |
ASX - By Stock
|
23K
|
13M
|
3
|
|
ASX - By Stock
|
BRN |
Re:
Akida Documentation
|
|
TTE
|
75 |
58K |
4 |
17/02/20 |
17/02/20 |
ASX - By Stock
|
75
|
58K
|
4
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
TTE
|
23K |
13M |
6 |
17/02/20 |
17/02/20 |
ASX - By Stock
|
23K
|
13M
|
6
|
|
ASX - By Stock
|
BRN |
Re:
Akida Documentation
|
|
TTE
|
75 |
58K |
3 |
17/02/20 |
17/02/20 |
ASX - By Stock
|
75
|
58K
|
3
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
TTE
|
23K |
13M |
8 |
14/02/20 |
14/02/20 |
ASX - By Stock
|
23K
|
13M
|
8
|
|
ASX - By Stock
|
BRN |
Re:
BrainChip's Akida Development Environment Now Freely Available for Use
|
|
TTE
|
150 |
104K |
7 |
14/02/20 |
14/02/20 |
ASX - By Stock
|
150
|
104K
|
7
|
|
ASX - By Stock
|
BRN |
Re:
BrainChip's Akida Development Environment Now Freely Available for Use
|
|
TTE
|
150 |
104K |
10 |
14/02/20 |
14/02/20 |
ASX - By Stock
|
150
|
104K
|
10
|
|
ASX - By Stock
|
BRN |
Re:
BrainChip's Akida Development Environment Now Freely Available for Use
|
|
TTE
|
150 |
104K |
19 |
14/02/20 |
14/02/20 |
ASX - By Stock
|
150
|
104K
|
19
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
TTE
|
23K |
13M |
1 |
14/02/20 |
14/02/20 |
ASX - By Stock
|
23K
|
13M
|
1
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
TTE
|
23K |
13M |
0 |
13/02/20 |
13/02/20 |
ASX - By Stock
|
23K
|
13M
|
0
|
|
ASX - By Stock
|
BUD |
Re:
Live webinar discussion
|
|
TTE
|
126 |
68K |
3 |
13/02/20 |
13/02/20 |
ASX - By Stock
|
126
|
68K
|
3
|
|
ASX - By Stock
|
BUD |
Re:
Live webinar discussion
|
|
TTE
|
126 |
68K |
3 |
13/02/20 |
13/02/20 |
ASX - By Stock
|
126
|
68K
|
3
|
|
ASX - By Stock
|
BRN |
Re:
BrainChip's Akida Development Environment Now Freely Available for Use
|
|
TTE
|
150 |
104K |
1 |
13/02/20 |
13/02/20 |
ASX - By Stock
|
150
|
104K
|
1
|
|
ASX - By Stock
|
BRN |
Re:
BrainChip's Akida Development Environment Now Freely Available for Use
|
|
TTE
|
150 |
104K |
0 |
13/02/20 |
13/02/20 |
ASX - By Stock
|
150
|
104K
|
0
|
|